New Pill's first human test begins: is it safe?

NCT ID NCT07285967

Summary

This is the first study in humans of a new oral medication called YR011. Researchers will test its safety and how the body processes it in 64 healthy volunteers. The study will give people single and multiple doses to check for side effects before testing in patients with specific conditions.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.